Article
Genetic Modifiers of Liver Disease in Cystic Fibrosis
8 Sept 2009
Abstract excerpt
CONTEXT: A subset (approximately 3%-5%) of patients with cystic fibrosis (CF) develops severe liver disease with portal hypertension. OBJECTIVE: To assess whether any of 9 polymorphisms in 5 candidate genes (alpha(1)-antitrypsin or alpha(1)-antiprotease [SERPINA1], angiotensin-converting enzyme [ACE], glutathione S-transferase [GSTP1], mannose-binding lectin 2 [MBL2], and transforming growth factor beta1 [TGFB1])...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
